Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model

Oncology Reports

Volumn 7, Issue 6, 2000, Pages 1377-1381

  Alshafie, Galal A ^a   Abou Issa, Hussein M ^a,b   Seibert, Karen ^c   Harris, Randall E ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c PFIZER INC   (United States)

Author keywords

Antineoplastic; Celecoxib; NSAIDs; Prostaglandin; Rat mammary cancer

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; CARCINOGEN; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ADENOCARCINOMA; ANIMAL; ARTICLE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; EATING; EXPERIMENTAL NEOPLASM; FEMALE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CARCINOGENS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; EATING; FEMALE; ISOENZYMES; MAMMARY NEOPLASMS, EXPERIMENTAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES;

EID: 0034320268     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.6.1377     Document Type: Article

References (28)

1. Singletary ES, Bevers T, Dempsy P, Farrar WB, Garber J, Harris RE, Helvie M, Jacobs M, Pass H, Patterson-Smith ML, Taranto S and Venta LA: Screening for and evaluation of suspicious breast lesions. Oncology 12: 89-138, 1998.
2. Rosenberg L: Non-steroidal anti-inflammatory drugs and cancer. Prev Med 24: 107-109, 1995.
3. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DO, Hoover R and Faumeni JF: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85: 307-311, 1993.
4. Harris RE, Kasbari S and Farrar WB: Prospective study of non-steroidal drugs and breast cancer. Oncol Rep 6: 71-73, 1999.
5. Harris RE, Namboodiri KK and Farrar WB: Non-steroidal anti-inflammatory drugs and breast cancer. Epidemiology 7: 203-205, 1996.
6. Kune GA, Kune S and Watson LF: Colorectal cancer risk, chronic illnesses, operations and medications. Case-control results from the Melbourne Colorectal Cancer Study. Cancer Res 48: 4399-4404, 1988.
7. Alshafic GA, Harris RE, Robertson FM, Parrett ML, Ross M and Abou-Issa H: Comparative chemopreventive activity of Ibuprofen and N-(4-hydroxyphenyl) Retinamide against the development and growth of rat mammary adenocarcinomas. Anticancer Res 19: 3031-3036, 1999.
8. Ramchurren N and Karmali RA: Effects of gamma-linolenic and dihomo-gamma-linolenic fatty acids on 7,12-dimethylbenz(a) anthracene mammary tumors in rats. Prostaglandins Leukot Essent Fatty Acids 53: 95-101, 1995.
9. Lee PP and Ip MM: Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipooxygenase. Prostaglandins Leukot Essent Fatty Acids 45: 21-31, 1992.
10. Carter CA, Milholland RJ, Shea W and Ip MM: Effect of prostaglandins synthetase inhibitor Indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rat fed different levels of fat. Cancer Res 43: 3559-3562, 1983.
11. Perrira MA, Barnes LH, Steele VE, Kelloff GV and Lubet RA: Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer on rats. Carcinogenesis 17: 373-376, 1996.
12. Δ716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 87: 803-809, 1996.
13. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR and Offerhaus GJ: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Eng J Med 328: 1313-1316, 1993.
14. Thun MJ, Nambooderi MM and Heath CW: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593-1596, 1991.
15. Joarder FS, Abou-Issa H, Robertson FM, Parrett, Alshafie GA and Harris RE: Growth arrest of DMBA-induced mammary carcino-genesis with Ibuprofen treatment in female Sprague-Dawley rats. Oncol Rep 4: 1271-1273, 1997.
16. Goppelt Struebe M: Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression. Prostaglandins Leukot Essent Fatty Acids 52: 213-222, 1995.
17. O'Neill GP and Ford-Hutchinson AW: Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330: 156-160, 1993.
18. Herschman HR: Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 13: 241-256, 1994.
19. Ramesha CS: Human and rat cyclooxygenases are pharmacologically distinct. In: Eicosanoids and Other Bioactive Lipids in Cancer Inflammation and Radiation Injury 3. Honn et al (eds). Plenum Press, NY, pp67-71, 1997.
20. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA and Prescott SM: Mol cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268: 9049-9054, 1993.
21. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ and Seibert K: Antiangiogenic and antitumor activities of Cyclooxygenase-2 Inhibitors. Cancer Res 60: 1306-1311, 2000.
22. Tsujii M and DuBois RN: Alteration in cellular adhesion and apoptosis in epithelial cells over-expressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501, 1995.
23. Lu X, Xie W and Reed D: Non-steroidal ant-inflammatory drugs cause apoptosis and inhibit cyclooxygenase in chicken embryo fibroblasts. Proc Natl Acad Sci USA 92: 7961-7965, 1995.
24. 2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137: 5739-5742, 1996.
25. Dickson RB and Lippman ME: Molecular basis of breast cancer. In: The Molecular Basis of Cancer. Mendelson J, Howley PM, Israel MA and Liotta LA (eds). W.B. Saunders Company, Philadelphia, 1995.
26. Ebehart CE, Coffey RJ, Radhika A, Giardiello FM, Rerrenbach S and DuBois RN: Up-regulation of cyclooxygenasc-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
27. 2 production and metabolism in human breast cancer cells and fibroblasts. Regulation by inflammatory mediators. Br J Cancer 72: 1412-1419, 1995.
28. Parrett ML, Harris RE, Joarder FS, Clausen KP and Robertson FM: Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol 10: 503-507, 1997.